Rothschild Asset Management Inc. boosted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 10,170.5% during the third quarter, Holdings Channel reports. The institutional investor owned 287,574 shares of the healthcare conglomerate’s stock after buying an additional 284,774 shares during the period. UnitedHealth Group comprises approximately 0.7% of Rothschild Asset Management Inc.’s investment portfolio, making the stock its 21st largest position. Rothschild Asset Management Inc.’s holdings in UnitedHealth Group were worth $40,260,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Shell Asset Management Co. raised its stake in UnitedHealth Group by 9.4% in the second quarter. Shell Asset Management Co. now owns 218,119 shares of the healthcare conglomerate’s stock valued at $30,798,000 after buying an additional 18,675 shares during the last quarter. Daiwa Securities Group Inc. raised its stake in UnitedHealth Group by 7.0% in the second quarter. Daiwa Securities Group Inc. now owns 207,049 shares of the healthcare conglomerate’s stock valued at $29,235,000 after buying an additional 13,550 shares during the last quarter. Sigma Planning Corp raised its stake in UnitedHealth Group by 8.9% in the second quarter. Sigma Planning Corp now owns 7,509 shares of the healthcare conglomerate’s stock valued at $1,060,000 after buying an additional 613 shares during the last quarter. Meeder Asset Management Inc. raised its stake in UnitedHealth Group by 0.7% in the second quarter. Meeder Asset Management Inc. now owns 34,950 shares of the healthcare conglomerate’s stock valued at $4,934,000 after buying an additional 228 shares during the last quarter. Finally, Robeco Institutional Asset Management B.V. raised its stake in UnitedHealth Group by 0.6% in the second quarter. Robeco Institutional Asset Management B.V. now owns 438,040 shares of the healthcare conglomerate’s stock valued at $61,853,000 after buying an additional 2,743 shares during the last quarter. 84.80% of the stock is owned by institutional investors.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

UnitedHealth Group Incorporated (NYSE:UNH) opened at 161.80 on Friday. The company has a market capitalization of $154.00 billion, a price-to-earnings ratio of 23.90 and a beta of 0.67. The company’s 50-day moving average price is $160.37 and its 200 day moving average price is $145.70. UnitedHealth Group Incorporated has a 12 month low of $108.83 and a 12 month high of $164.00.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 18th. The healthcare conglomerate reported $2.17 EPS for the quarter, beating analysts’ consensus estimates of $2.08 by $0.09. The firm earned $46.30 billion during the quarter, compared to analyst estimates of $46.09 billion. UnitedHealth Group had a net margin of 3.62% and a return on equity of 19.92%. The business’s revenue for the quarter was up 11.6% on a year-over-year basis. During the same period in the previous year, the business earned $1.77 EPS. Analysts forecast that UnitedHealth Group Incorporated will post $8.02 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This article was posted by Watch List News and is the propert of of Watch List News. If you are viewing this article on another site, it was copied illegally and reposted in violation of international trademark & copyright law. The correct version of this article can be viewed at http://www.watchlistnews.com/rothschild-asset-management-inc-raises-stake-in-unitedhealth-group-incorporated-unh/1061250.html.

Several research firms have issued reports on UNH. Barclays PLC restated a “buy” rating and issued a $187.00 price objective on shares of UnitedHealth Group in a research note on Monday, January 9th. Jefferies Group restated a “buy” rating and issued a $2.30 price objective on shares of UnitedHealth Group in a research note on Tuesday. Piper Jaffray Companies began coverage on UnitedHealth Group in a research note on Tuesday, January 3rd. They issued an “overweight” rating and a $188.00 price objective on the stock. Vetr upgraded UnitedHealth Group from a “buy” rating to a “strong-buy” rating and set a $189.00 price objective on the stock in a research note on Wednesday, December 28th. Finally, Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $180.00 price objective on the stock in a research note on Saturday, December 3rd. Twenty-two investment analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. UnitedHealth Group presently has a consensus rating of “Buy” and an average price target of $165.62.

In other news, Director Richard T. Burke sold 45,000 shares of the business’s stock in a transaction on Thursday, December 8th. The shares were sold at an average price of $158.66, for a total transaction of $7,139,700.00. Following the completion of the transaction, the director now directly owns 1,944,949 shares in the company, valued at approximately $308,585,608.34. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Richard T. Burke sold 15,000 shares of the business’s stock in a transaction on Thursday, December 15th. The shares were sold at an average price of $159.80, for a total transaction of $2,397,000.00. Following the transaction, the director now owns 1,940,030 shares of the company’s stock, valued at $310,016,794. The disclosure for this sale can be found here. Insiders own 1.65% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

5 Day Chart for NYSE:UNH

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.